Bluebird bio Inc

NASDAQ:BLUE   4:00:00 PM EDT
1.28
-0.08 (-6.23%)
7:52:36 PM EDT: $1.28 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)231.34M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$19.51 Million
Adjusted EPS-$0.45
See more estimates
10-Day MA$1.35
50-Day MA$1.25
200-Day MA$2.68
See more pivots

Bluebird bio Inc Stock, NASDAQ:BLUE

60 Binney Street, 455 Grand Union Boulevard, Somerville, Massachusetts 02145
United States of America
Phone: +1.339.499.9300
Number of Employees: 323

Description

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.